173 related articles for article (PubMed ID: 34321580)
1. A prospective study revealing the role of an immune-related eRNA, WAKMAR2, in breast cancer.
Wang L; Liu J; Tai J; Zhou N; Huang T; Xue Y; Quan Z
Sci Rep; 2021 Jul; 11(1):15328. PubMed ID: 34321580
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer.
Zhang Z; Lee JH; Ruan H; Ye Y; Krakowiak J; Hu Q; Xiang Y; Gong J; Zhou B; Wang L; Lin C; Diao L; Mills GB; Li W; Han L
Nat Commun; 2019 Oct; 10(1):4562. PubMed ID: 31594934
[TBL] [Abstract][Full Text] [Related]
3. Functional annotation of structural ncRNAs within enhancer RNAs in the human genome: implications for human disease.
Ren C; Liu F; Ouyang Z; An G; Zhao C; Shuai J; Cai S; Bo X; Shu W
Sci Rep; 2017 Nov; 7(1):15518. PubMed ID: 29138457
[TBL] [Abstract][Full Text] [Related]
4. Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential.
Lee JH; Xiong F; Li W
RNA Biol; 2020 Nov; 17(11):1550-1559. PubMed ID: 31916476
[TBL] [Abstract][Full Text] [Related]
5. Current Advances on the Important Roles of Enhancer RNAs in Molecular Pathways of Cancer.
Wang R; Tang Q
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073237
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
[No Abstract] [Full Text] [Related]
7. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation.
Li W; Notani D; Ma Q; Tanasa B; Nunez E; Chen AY; Merkurjev D; Zhang J; Ohgi K; Song X; Oh S; Kim HS; Glass CK; Rosenfeld MG
Nature; 2013 Jun; 498(7455):516-20. PubMed ID: 23728302
[TBL] [Abstract][Full Text] [Related]
8. Genetic, Pharmacogenomic, and Immune Landscapes of Enhancer RNAs Across Human Cancers.
Zhang Z; Luo M; Li Q; Liu Y; Lussier C; Zhang J; Ye Y; Guo AY; Han L
Cancer Res; 2022 Mar; 82(5):785-790. PubMed ID: 35022213
[TBL] [Abstract][Full Text] [Related]
9. Single-cell profiling reveals that eRNA accumulation at enhancer-promoter loops is not required to sustain transcription.
Rahman S; Zorca CE; Traboulsi T; Noutahi E; Krause MR; Mader S; Zenklusen D
Nucleic Acids Res; 2017 Apr; 45(6):3017-3030. PubMed ID: 27932455
[TBL] [Abstract][Full Text] [Related]
10. eRNAs are required for p53-dependent enhancer activity and gene transcription.
Melo CA; Drost J; Wijchers PJ; van de Werken H; de Wit E; Oude Vrielink JA; Elkon R; Melo SA; Léveillé N; Kalluri R; de Laat W; Agami R
Mol Cell; 2013 Feb; 49(3):524-35. PubMed ID: 23273978
[TBL] [Abstract][Full Text] [Related]
11. Enhancer-derived RNA: A Primer.
Liu F
Genomics Proteomics Bioinformatics; 2017 Jun; 15(3):196-200. PubMed ID: 28533025
[TBL] [Abstract][Full Text] [Related]
12. eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer.
Zhang X; Pang P; Jiang M; Cao Q; Li H; Xu Y; Li Y; Chen X; Han J
Dis Markers; 2020; 2020():8847986. PubMed ID: 33029258
[TBL] [Abstract][Full Text] [Related]
13. GAS1RR, an immune-related enhancer RNA, is related to biochemical recurrence-free survival in prostate cancer.
Xiong Z; Ge Y; Xiao J; Wang Y; Li L; Ma S; Lan L; Liu B; Qin B; Luan Y; Yang C; Ye Z; Wang Z
Exp Biol Med (Maywood); 2023 Jan; 248(1):1-13. PubMed ID: 36408742
[TBL] [Abstract][Full Text] [Related]
14. Enhancer RNAs and regulated transcriptional programs.
Lam MT; Li W; Rosenfeld MG; Glass CK
Trends Biochem Sci; 2014 Apr; 39(4):170-82. PubMed ID: 24674738
[TBL] [Abstract][Full Text] [Related]
15. HeRA: an atlas of enhancer RNAs across human tissues.
Zhang Z; Hong W; Ruan H; Jing Y; Li S; Liu Y; Wang J; Li W; Diao L; Han L
Nucleic Acids Res; 2021 Jan; 49(D1):D932-D938. PubMed ID: 33119754
[TBL] [Abstract][Full Text] [Related]
16. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
17. Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network.
Liang Y; Lu Q; Li W; Zhang D; Zhang F; Zou Q; Chen L; Tong Y; Liu M; Wang S; Li W; Ren X; Xu P; Yang Z; Dong S; Zhang B; Huang Y; Li D; Wang H; Yu W
Nucleic Acids Res; 2021 Sep; 49(15):8556-8572. PubMed ID: 34329471
[TBL] [Abstract][Full Text] [Related]
18. eNEMAL, an enhancer RNA transcribed from a distal MALAT1 enhancer, promotes NEAT1 long isoform expression.
Stone JK; Vukadin L; Ahn EE
PLoS One; 2021; 16(5):e0251515. PubMed ID: 34019552
[TBL] [Abstract][Full Text] [Related]
19. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
Tian X; Zhang Z
IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
[TBL] [Abstract][Full Text] [Related]
20. Non-coding RNA derived from the region adjacent to the human HO-1 E2 enhancer selectively regulates HO-1 gene induction by modulating Pol II binding.
Maruyama A; Mimura J; Itoh K
Nucleic Acids Res; 2014 Dec; 42(22):13599-614. PubMed ID: 25404134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
